Chukwuma Ndibe, MD
Fax: (770) 385-4456
Business hours
| Monday | 8:00am to 4:00pm |
| Tuesday | 8:00am to 4:00pm |
| Wednesday | 8:00am to 4:00pm |
| Thursday | 8:00am to 4:00pm |
| Friday | 8:00am to 4:00pm |
| Saturday | - |
| Sunday | - |
About us
Chuma Ndibe, M.D., earned his medical degree from University of Nigeria College of Medicine and completed his residency at Morehouse School of Medicine. He is board certified in Medical Oncology, Hematology and Internal Medicine. Prior to joining Piedmont, he was an oncologist/hematologist at Cancer Care Center of Tuscaloosa. Dr. Ndibe specializes in the diagnosis and treatment of cancer and blood disorders. Dr. Ndibe has a special interest in the treatment of lung, breast, colon, prostate, lymphoma and all other cancers. In his spare time, Dr. Ndibe enjoys spending time with his family, reading books and traveling. Dr. Ndibe is accepting new patients and welcomes most major insurance plans.
Schedule an Appointment Today!
| Languages | English |
| Tags | abdominal cancer, abdominal cancer chemotherapy, abnormal protein, abnormal urine cytology, adamantinoma, adenocarcinoma of the bladder, adjuvant chemotherapy, adolescent and young adult cancer (aya), adrenal neoplasm, adult t cell lymphoma, advanced malignancies, adverse effects to anticoagulants, aids related malignancies, alk negative anaplastic large cell lymphoma, alveolar soft part sarcoma, anal cancer chemotherapy, anaplastic large cell lymphoma, anemia, anemia and bone marrow disorders, anemia of chronic disease, anemia of pregnancy, anorectal cancer chemotherapy, anticoagulation, aplastic anemia, appendiceal cancer chemotherapy, aranesp injection, b cell lymphoproliferative disorder, b12 deficiency anemia, biliary tract cancer chemotherapy, bladder cancer, bladder cancer chemotherapy, bladder cancer genomics, blood cancer, blood cancer chemotherapy, blood clot, blood clotting disorder, blood disorders, blood transfusion therapy, bone sarcoma, brain cancer chemotherapy, brain cancer genomics, brain metastases, breast cancer, breast cancer biological targeted therapy, breast cancer chemotherapy, breast cancer genetics, bronchus associated lymphoid tissue lymphoma, burkitt lymphoma, cancer, cancer chemotherapy, cancer during pregnancy, cancer genomics, cancer of the joints, cancer of the muscles, cancer pain, cancer related fatigue, cancer related psychiatric disorder, cancer related sexual concerns, cancer related stress disorder, cancer risk, cancer survivor, carcinoma of unknown primary, cervical and endometrial cancers, cervical cancer, cervical cancer chemotherapy, cervical cancer genomics, chemoradiation, chronic lymphocytic leukemia, chronic myelocytic leukemia, chronic myelomonocytic leukemia, chronic neutrophilic leukemia, cns lymphoma, coagulation disorders, colon cancer chemotherapy, colon cancer genomics, colorectal cancer chemotherapy, colorectal malignancy, congenital sideroblastic anemia (csa), consolidation chemotherapy, cutaneous b cell lymphoma, cutaneous lymphoma, decreased hemoglobin, deep thrombophlebitis, deep vein thrombosis, ductal carcinoma in situ (dcis), ear and temporal bone cancer, ear canal cancer, ear cancer, early detection of cancer, egfr mutation, egfr translocation, electrolyte abnormalities in cancer patients, elevated ferritin, elevated hemoglobin, elevated transferrin saturation, endocrine complications of cancer therapy, endometrial cancer, endometrial cancer chemotherapy, endometrial cancer genomics, erythrocytosis |
| Video | https://www.youtube.com/watch?v=T9NfAvvVi6I |